The Medicines Watchdog has reported a staggering 370% increase in the first five months of this year in the seizure of counterfeit weight-loss drugs compared to the total for the whole of 2023, according to the latest statistics. The Health Products Regulatory Authority (HPRA) has this Friday issued a public warning about the hazards associated with phony versions of semaglutide products like Ozempic and Wegovy.
These drugs are often prescribed for diabetes and obesity, but a surge in their use has been seen due to endorsements by online personalities and celebrities keen to showcase their weight-loss effects. Counterfeit drugs are imitation medications designed to look like the genuine article. However, the HPRA has cautioned the public that they may contain harmful ingredients or incorrect doses, thereby compromising the health and efficacy of any vital treatment that a patient might need.
Up to the end of May 2024, the HPRA has seized a total of 1,196 units of fake semaglutide, which includes items such as tablets, vials of white powder or transparent liquid labelled semaglutide, and boxed pens marketed as a generic form of the product. Compared to this, 254 units were intercepted in 2023, a rise from the 32 units seized in 2022.
While HPRA has acknowledged the surge in seizures and overall desire for these products, it maintains the quantities are relatively small in contrast to seizures of other products. Nonetheless, the HPRA is keeping a vigilant eye on the situation.
The HPRA’s announcement follows a World Health Organisation warning about the increasing global trend of these fake products being discovered in various markets. Alongside its regulatory duties, the HPRA regularly monitors and takes action against websites, social media platforms and ecommerce sites selling prescription medications online to the Irish market.
These products, including Ozempic, Rybelsus and Wegovy, all contain the active component semaglutide, states the HPRA. In 2023, HPRA removed or modified 169 websites or social media pages advertising or supplying semaglutide. A further 144 pages have been removed or altered thus far into 2024.
The HPRA emphasised that individuals should always consult with healthcare experts regarding any health worries they might have, rather than resorting to internet sites. It advocated for the importance of obtaining prescribed medications utilising regular procedures, which involves getting a prescription from one’s doctor and having it fulfilled at a local chemist’s shop.